Identification of the real molecular target for HIV inhibitors [2]

Trends in Pharmacological Sciences

Volumn 21, Issue 5, 2000, Pages 167-168

  De Clercq, E ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA N ACETYLNONA DEXTRO ARGININE AMIDE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CHEMOKINE RECEPTOR CXCR4; CICHORIC ACID; INTEGRASE; N (6 AMINOHEXYL)GLYCYL N (3 GUANIDINOPROPYL)GLYCYL N (3 GUANIDINOPROPYL)GLYCYL N BENZYLGLYCYL N (3 GUANIDINOPROPYL)GLYCYL DEXTRO LYSYL DEXTRO LYSYL DEXTRO ARGINYL DEXTRO PROLINAMIDE; SURAMIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; ZINTEVIR;

ANTIVIRAL ACTIVITY; DRUG DEVELOPMENT; DRUG MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS 1; LETTER; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION; VIRUS REPLICATION;

EID: 0034192164     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01461-9     Document Type: Letter

References (15)

1. E. De Clercq Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses Cancer Lett. 8 1979 9 22
2. H. Mitsuya Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III Science 226 1984 172 174
3. + cells J. Acquired Immune Defic. Syndr. 2 1989 10 15
4. C.L. Hill Anti-HIV-1 activity, toxicity, and stability studies of representative structural families of polyoxometalates J. Med. Chem. 33 1990 2767 2772
5. N. Yamamoto Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents Mol. Pharmacol. 42 1992 1109 1117
6. J.O. Ojwang T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1 Antimicrob. Agents Chemother. 39 1995 2426 2435
7. P. Cherepanov Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1 Mol. Pharmacol. 52 1997 771 780
8. J.A. Esté Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (zintevir) Mol. Pharmacol. 53 1998 340 345
9. F. Hamy An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication Proc. Natl. Acad. Sci. U. S. A. 94 1997 3548 3553
10. D. Daelemans A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry Mol. Pharmacol. 57 2000 116 124
11. M. Sumner-Smith Antiherpetic activities of N -α-acetyl-nona- d -arginine amide acetate Drugs Exp. Clin. Res. 21 1995 1 6
12. B.J. Doranz A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor J. Exp. Med. 186 1997 1395 1400
13. W.E. Robinson Jr Inhibitors of HIV-1 replication that inhibit HIV integrase Proc. Natl. Acad. Sci. U. S. A. 93 1996 6326 6331
14. P.J. King W.E. Robinson Jr Resistance to the anti-human immunodeficiency virus type 1 compound l -chicoric acid results from a single mutation at amino acid 140 of integrase J. Virol. 72 1998 8420 8424
15. Pluymers, W. et al. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. Mol. Pharmacol.